Page last updated: 2024-10-22

altretamine and Leukemia, Myeloid, Acute

altretamine has been researched along with Leukemia, Myeloid, Acute in 2 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research Excerpts

ExcerptRelevanceReference
"Thirteen cases of acute nonlymphocytic leukemia occurred among 5455 patients, as compared to 0."1.26Acute leukemia after alkylating-agent therapy of ovarian cancer. ( Fraumeni, JF; Hoover, R; Reimer, RR; Young, RC, 1977)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reimer, RR1
Hoover, R1
Fraumeni, JF1
Young, RC1
Grubb, BP1
Thant, M1

Other Studies

2 other studies available for altretamine and Leukemia, Myeloid, Acute

ArticleYear
Acute leukemia after alkylating-agent therapy of ovarian cancer.
    The New England journal of medicine, 1977, Jul-28, Volume: 297, Issue:4

    Topics: Acute Disease; Alkylating Agents; Altretamine; Chlorambucil; Cyclophosphamide; Female; Fluorouracil;

1977
Acute myelocytic leukemia in a patient treated with hexamethylmelamine.
    The American journal of the medical sciences, 1986, Volume: 292, Issue:6

    Topics: Aged; Altretamine; Female; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Ovarian Neo

1986